Stoke Therapeutics, Inc.

STOK·NASDAQ·$31.03Share Price as of 11/2·$2BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/03/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/16/26 10-QQ3 ended 09/30/2511/04/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report09/25/26 8-KCurrent report08/03/26 8-KCurrent report08/03/26 8-KCurrent report06/30/26

Prospectuses and Registrations

424B5Prospectus supplement08/03/26 S-8Registration of securities for employees08/03/26 S-3ASRAutomatic shelf registration03/18/26 S-8Registration of securities for employees03/16/26 S-3Shelf registration07/09/25

Proxies

DEF 14ADefinitive proxy04/22/26 DEFA14AAdditional proxy materials04/22/26 DEF 14ADefinitive proxy04/22/25 DEFA14AAdditional proxy materials04/22/25 DEF 14ADefinitive proxy04/23/24

Ownership

144Proposed sale of securities10/21/26 144Proposed sale of securities10/02/26 Form 4Insider transaction10/02/26 Form 4Insider transaction10/02/26 SC 13GBeneficial ownership09/30/26

Other

ARSAnnual report to shareholders04/22/26 EFFECTRequest for effectiveness07/11/25 CORRESPCorrespondence with the SEC07/09/25 UPLOADLetter from the SEC06/30/25 DRSDRS06/26/25